Europe PMC
open access
Academic treatment optimization studies in oncology and internal medicine: a risk- and burden-adapted regulatory framework for the European Union
Academic treatment optimization studies (TOS) play an important role in determining how established and emerging treatments should be combined, sequenced, intensified, de-intensified, or otherwise optimized in routine clinical care. Unlike commercial clinical trials, which primarily support the deve
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 21 U.S.C. § 360bbb-8a — Optimizing global clinical trials#577326
- Uncertainty and novel clinical trial designs in oncology - when should equipoise matter?#1158604
- Advancing the adoption of oncology decision support tools in Europe: insights from CAN.HEAL.#122836
- TrialAtlas: Multi-Agent Research Organization for Clinical Trial Design and Optimization#1036248
- A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma#982278
Record · ID 1469516
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive